Bristol-Myers Squibb is trading near all-time high dividend and free cash flow yields. Learn why BMY stock is a Buy.

Tesla slides ahead of quarterly earnings scheduled for Tuesday, and Nvidia tumbles with the chip maker a victim of the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Finding a new place to work is a job in and of itself, as anyone who’s gone job-seeking in the last three or so years can ...

The simplified requirements for Camzyos are expected to ease prior contraindications, thereby simplifying treatment and ...

The FDA has updated the labeling for Camzyos to reduce echocardiogram monitoring requirements for patients in the maintenance phase and contraindications.

Soon after graduation this spring, Neha Bhat will start a job as a Global Marketing New Analyst for Goldman Sachs, a position ...

Bristol-Myers Squibb's blockbuster aspirations for Reblozyl have been given a boost by the FDA after it approved the drug as a first-line treatment for anaemia in patients with myelodysplastic ...

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of colorectal cancer.

Pfizer's stock has suffered a brutal 16.44% drop in April, despite flexing strong Q4 earnings with a 37.2% EPS beat. Over the ...